Villanacci V - Search Results

1

Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth.

Ghirardi M, Nascimbeni R, Villanacci V, Fontana MG, Di Betta E, Salerni B. Ghirardi M, et al. Among authors: villanacci v. Eur Surg Res. 1999;31(3):272-80. doi: 10.1159/000008703. Eur Surg Res. 1999. PMID: 10352356

2

Effect of cholecystokinin-B gastrin receptor blockade on chemically induced colon carcinogenesis in mice: follow-up at 52 weeks.

Fontana MG, Moneghini D, Villanacci V, Donato F, Rindi G. Fontana MG, et al. Among authors: villanacci v. Digestion. 2002;65(1):35-40. doi: 10.1159/000051929. Digestion. 2002. PMID: 11961341

3

Distribution of 1,2 DMH-induced colonic aberrant crypt foci after administration of a gastrin receptor antagonist (CR2945), in the murine model.

Fontana MG, Ghirardi M, Moneghini D, La Pinta M, Villanacci V, Donato F, Salerni B. Fontana MG, et al. Among authors: villanacci v. Ann Ital Chir. 2001 Mar-Apr;72(2):221-5. Ann Ital Chir. 2001. PMID: 11552478

4

Inhibitory effect of a gastrin receptor antagonist, CR2945, on 1, 2-dimethylhydrazine-induced colorectal cancer in mice.

Fontana MG, Donato F, Villanacci V, Ghirardi M, Moneghini D, Di Betta E, Salerni B. Fontana MG, et al. Among authors: villanacci v. Eur Surg Res. 1999;31(5):406-11. doi: 10.1159/000008719. Eur Surg Res. 1999. PMID: 10529554

5

Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease.

Nascimbeni R, Villanacci V, Mariani PP, Di Betta E, Ghirardi M, Donato F, Salerni B. Nascimbeni R, et al. Among authors: villanacci v. Am J Surg Pathol. 1999 Oct;23(10):1256-63. doi: 10.1097/00000478-199910000-00011. Am J Surg Pathol. 1999. PMID: 10524527

6

The decrease of mineralcorticoid receptor drives angiogenic pathways in colorectal cancer.

Tiberio L, Nascimbeni R, Villanacci V, Casella C, Fra A, Vezzoli V, Furlan L, Meyer G, Parrinello G, Baroni MD, Salerni B, Schiaffonati L. Tiberio L, et al. Among authors: villanacci v. PLoS One. 2013;8(3):e59410. doi: 10.1371/journal.pone.0059410. Epub 2013 Mar 28. PLoS One. 2013. PMID: 23555666 Free PMC article.

7

Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci.

Nascimbeni R, Donato F, Ghirardi M, Mariani P, Villanacci V, Salerni B. Nascimbeni R, et al. Among authors: villanacci v. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):753-7. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12163329

8

Prognostic variables for cancer-related survival in node-negative colorectal carcinomas.

Di Fabio F, Nascimbeni R, Villanacci V, Baronchelli C, Bianchi D, Fabbretti G, Casella C, Salerni B. Di Fabio F, et al. Among authors: villanacci v. Dig Surg. 2004;21(2):128-33. doi: 10.1159/000077348. Epub 2004 Mar 16. Dig Surg. 2004. PMID: 15026608

9

Hereditary multiple exostoses and juvenile colon carcinoma: A case with a common genetic background?

Pata G, Nascimbeni R, Di Lorenzo D, Gervasi M, Villanacci V, Salerni B. Pata G, et al. Among authors: villanacci v. J Surg Oncol. 2009 Nov 1;100(6):520-2. doi: 10.1002/jso.21365. J Surg Oncol. 2009. PMID: 19653241

10

Endocrine tumors of the digestive tract and pancreas: histogenesis, diagnosis and molecular basis.

Rindi G, Villanacci V, Ubiali A, Scarpa A. Rindi G, et al. Among authors: villanacci v. Expert Rev Mol Diagn. 2001 Sep;1(3):323-33. doi: 10.1586/14737159.1.3.323. Expert Rev Mol Diagn. 2001. PMID: 11901838 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results